Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

CNBC News

26 January 2024 - Bristol Myers Squibb CEO Chris Boerner and another unnamed pharmaceutical CEO accepted initial invitations to testify.

The CEOs of Merck and Johnson & Johnson have voluntarily agreed to testify at an upcoming Senate hearing on high drug prices in the US, Senator Bernie Sanders announced Friday, as law makers ramp up efforts to rein in health care costs for Americans.

The Senate Health, Education, Labor and Pensions Committee’s hearing is scheduled for 8 February 2024.

Read CNBC News article

Michael Wonder

Posted by:

Michael Wonder